FTC says Minnesota plan will raise health costs for consumers

29 March 2009

According to the staff of the US Federal Trade Commission, legislation pending before the State of Minnesota legislature that seeks to exempt  certain activities by state health care cooperatives from federal and  state antitrust law would likely raise health care costs and reduce  insurance coverage for consumers there. The FTC's Bureau of Competition,  Bureau of Economics and Office of Policy Planning filed a detailed  comment with Minnesota State Representative Tom Emmer (Republican),  responding to his request for the FTC's views on Minnesota House Bill HF  No 120 and its companion legislation, Senate Bill SF No 203.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight